Physician profile
Ethan Robert Harlow
NPI 1013414101
$26,353.33
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,937 · 2021: $2,445 · 2022: $5,032 · 2023: $283 · 2024: $5,790 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $4,974 · Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,230.00 |
| Travel and Lodging | $4,973.82 |
| Food and Beverage | $1,736.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,300.91 | 2024-2025 | Inhance, Healix Knotless Peek, Na |
| Rock Medical Orthopedics, INC. | $9,264.15 | 2020-2022 | |
| Shoulder Innovations, INC. | $1,675.25 | 2024-2025 | Inset System |
| Stryker Corporation | $720.93 | 2022-2024 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Aequalis Perform+ |
| Prodigy Surgical Distribution, INC. | $554.90 | 2024 | |
| Depuy Synthes Sales INC. | $453.79 | 2024-2025 | Fms, Inhance |
| Arthrex, INC. | $318.62 | 2024-2025 | |
| Smith+Nephew, INC. | $64.78 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Harlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.